Dendritic cells immunotargeted therapy for atherosclerosis

Atherosclerosis, a chronic inflammatory disease, is markedly influenced by both immune and inflammatory reactions throughout its progression. Dendritic cells, as pivotal antigen-presenting entities, play a crucial role in the initiation of immune responses and the preservation of immunological homeo...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhaohui Li, Yanyan Yang, Jinbao Zong, Bei Zhang, Xiaolu Li, Hongzhao Qi, Tao Yu, Yongxin Li
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Acta Pharmaceutica Sinica B
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2211383524004866
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850070118342590464
author Zhaohui Li
Yanyan Yang
Jinbao Zong
Bei Zhang
Xiaolu Li
Hongzhao Qi
Tao Yu
Yongxin Li
author_facet Zhaohui Li
Yanyan Yang
Jinbao Zong
Bei Zhang
Xiaolu Li
Hongzhao Qi
Tao Yu
Yongxin Li
author_sort Zhaohui Li
collection DOAJ
description Atherosclerosis, a chronic inflammatory disease, is markedly influenced by both immune and inflammatory reactions throughout its progression. Dendritic cells, as pivotal antigen-presenting entities, play a crucial role in the initiation of immune responses and the preservation of immunological homeostasis. Accumulating data indicates that dendritic cells are present in healthy arteries and accumulate significantly in atherosclerotic plaques. Novel immunotherapeutic approaches and vaccination protocols have yielded substantial clinical advancements in managing chronic inflammatory diseases, with dendritic cell-centric modalities emerging for atherosclerotic management. In this review, we delineate the essential functions and underlying mechanisms of dendritic cells and their subsets in the modulation of atherosclerotic inflammation and immune responses. We underscore the immense promise of dendritic cell-based immunotherapeutic strategies, including vaccines and innovative combinations with nanotechnological drug delivery platforms for atherosclerosis treatment. We also discuss the challenges associated with dendritic cell immunotherapy and provide perspectives on the future direction of this field.
format Article
id doaj-art-d2c10c4b8be445ca859d24a27c5881d0
institution DOAJ
issn 2211-3835
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series Acta Pharmaceutica Sinica B
spelling doaj-art-d2c10c4b8be445ca859d24a27c5881d02025-08-20T02:47:37ZengElsevierActa Pharmaceutica Sinica B2211-38352025-02-0115279280810.1016/j.apsb.2024.12.029Dendritic cells immunotargeted therapy for atherosclerosisZhaohui Li0Yanyan Yang1Jinbao Zong2Bei Zhang3Xiaolu Li4Hongzhao Qi5Tao Yu6Yongxin Li7Department of Vascular Surgery, the Affiliated Hospital of Qingdao University, Qingdao, 266400, ChinaDepartment of Immunology, School of Basic Medicine, Qingdao University, Qingdao, 266071, ChinaClinical Laboratory, Central Laboratory, Qingdao Hiser Hospital Affiliated of Qingdao University (Qingdao Traditional Chinese Medicine Hospital), Qingdao, 266000, ChinaDepartment of Immunology, School of Basic Medicine, Qingdao University, Qingdao, 266071, ChinaDepartment of Cardiac Ultrasound, the Affiliated Hospital of Qingdao University, Qingdao, 266000, ChinaInstitute for Translational Medicine, the Affiliated Hospital of Qingdao University, Qingdao, 266021, ChinaDepartment of Cardiac Ultrasound, the Affiliated Hospital of Qingdao University, Qingdao, 266000, China; Institute for Translational Medicine, the Affiliated Hospital of Qingdao University, Qingdao, 266021, China; Corresponding authors.Department of Vascular Surgery, the Affiliated Hospital of Qingdao University, Qingdao, 266400, China; Corresponding authors.Atherosclerosis, a chronic inflammatory disease, is markedly influenced by both immune and inflammatory reactions throughout its progression. Dendritic cells, as pivotal antigen-presenting entities, play a crucial role in the initiation of immune responses and the preservation of immunological homeostasis. Accumulating data indicates that dendritic cells are present in healthy arteries and accumulate significantly in atherosclerotic plaques. Novel immunotherapeutic approaches and vaccination protocols have yielded substantial clinical advancements in managing chronic inflammatory diseases, with dendritic cell-centric modalities emerging for atherosclerotic management. In this review, we delineate the essential functions and underlying mechanisms of dendritic cells and their subsets in the modulation of atherosclerotic inflammation and immune responses. We underscore the immense promise of dendritic cell-based immunotherapeutic strategies, including vaccines and innovative combinations with nanotechnological drug delivery platforms for atherosclerosis treatment. We also discuss the challenges associated with dendritic cell immunotherapy and provide perspectives on the future direction of this field.http://www.sciencedirect.com/science/article/pii/S2211383524004866Dendritic cellAtherosclerosisImmunotherapyInflammationDelivery
spellingShingle Zhaohui Li
Yanyan Yang
Jinbao Zong
Bei Zhang
Xiaolu Li
Hongzhao Qi
Tao Yu
Yongxin Li
Dendritic cells immunotargeted therapy for atherosclerosis
Acta Pharmaceutica Sinica B
Dendritic cell
Atherosclerosis
Immunotherapy
Inflammation
Delivery
title Dendritic cells immunotargeted therapy for atherosclerosis
title_full Dendritic cells immunotargeted therapy for atherosclerosis
title_fullStr Dendritic cells immunotargeted therapy for atherosclerosis
title_full_unstemmed Dendritic cells immunotargeted therapy for atherosclerosis
title_short Dendritic cells immunotargeted therapy for atherosclerosis
title_sort dendritic cells immunotargeted therapy for atherosclerosis
topic Dendritic cell
Atherosclerosis
Immunotherapy
Inflammation
Delivery
url http://www.sciencedirect.com/science/article/pii/S2211383524004866
work_keys_str_mv AT zhaohuili dendriticcellsimmunotargetedtherapyforatherosclerosis
AT yanyanyang dendriticcellsimmunotargetedtherapyforatherosclerosis
AT jinbaozong dendriticcellsimmunotargetedtherapyforatherosclerosis
AT beizhang dendriticcellsimmunotargetedtherapyforatherosclerosis
AT xiaoluli dendriticcellsimmunotargetedtherapyforatherosclerosis
AT hongzhaoqi dendriticcellsimmunotargetedtherapyforatherosclerosis
AT taoyu dendriticcellsimmunotargetedtherapyforatherosclerosis
AT yongxinli dendriticcellsimmunotargetedtherapyforatherosclerosis